newsfilter
← Latest News
GlobeNewswire·

Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing

CORAL GABLES, Fla., March 09, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for oncology and